Minervini SEPA — 8 Parameter Audit
| Parameter | Result | Data |
|---|---|---|
|
Price above 150 & 200 DMA
Minervini SEPA · Criterion 1
|
FAIL | Price ₹760 · 150 DMA ₹776 · 200 DMA ₹771 |
|
150 DMA above 200 DMA
Minervini SEPA · Criterion 2
|
PASS | 150 DMA ₹776 vs 200 DMA ₹771 (+0.6%) |
|
200 DMA trending up ≥ 1 month
Minervini SEPA · Criterion 3
|
FAIL | 200 DMA slope: -0.49% over 4 weeks |
|
50 DMA above 150 & 200 DMA
Minervini SEPA · Criterion 4
|
PASS | 50 DMA ₹819 · 150 DMA ₹776 · 200 DMA ₹771 |
|
Price above 50 DMA
Minervini SEPA · Criterion 5
|
FAIL | Price ₹760 · 50 DMA ₹819 (-7.2%) |
|
Price within 25% of 52-week high
Minervini SEPA · Criterion 6
|
PASS | ₹760 vs 52W high ₹983 (-22.7%) |
|
Price ≥ 30% above 52-week low
Minervini SEPA · Criterion 7
|
FAIL | ₹760 vs 52W low ₹626 (+21.3%) |
|
RS Rating ≥ 70
Minervini SEPA · Criterion 8
|
FAIL | RS Rating: 63 (threshold: ≥70) |
Weinstein Stage Analysis
Base Stage 2
Advance Stage 3
Top Stage 4
Decline
APLLTD.NS is in Weinstein Stage 4 — the declining phase. Price is below all key moving averages, the 200 DMA is trending downward, and the structure reflects distribution. Position traders applying strict methodology have no participation during Stage 4.
Relative Strength Rating
Structural Analysis
Alembic Pharmaceuticals Limited is currently trading 7.2% below its 50-day moving average, with Weinstein Stage 4 confirmed by the moving average hierarchy.
The Minervini SEPA audit finds 3 of 8 parameters confirmed. The parameter(s) not confirmed: Price above 150 & 200 DMA, 200 DMA trending up, Price above 50 DMA, 30% above 52W low, RS Rating ≥70.
Sanjaya's Reading
Mitra, main dekh raha hoon Alembic Pharmaceuticals Limited ko — 3 criteria poore hain aath mein se.
Weinstein Stage 4 mein hai yeh instrument. अभी नहीं मित्र.
This is a static snapshot
This audit was generated from NSE closing data on 23 October 2026. Run a live audit with real-time data, animated criteria reveals, and Sanjaya's full narration.
Run a Live Audit — Free →Free tier includes Nifty 50 stocks · Pro unlocks full NSE universe
Frequently Asked Questions
APLLTD (Alembic Pharmaceuticals Limited) currently meets 3 of 8 Minervini SEPA parameters. APLLTD currently meets 3 of 8 Minervini SEPA parameters. The parameter(s) not confirmed: Price above 150 & 200 DMA, 200 DMA trending up, Price above 50 DMA, 30% above 52W low, RS Rating ≥70.
APLLTD is currently in Weinstein Stage 4. APLLTD.NS is in Weinstein Stage 4 — the declining phase. Price is below all key moving averages, the 200 DMA is trending downward, and the structure reflects distribution. Position traders applying strict methodology have no participation during Stage 4.
The Kasauti verdict for APLLTD is अभी नहीं मित्र (Does Not Pass Yet). The Kasauti verdict for APLLTD.NS is अभी नहीं मित्र — Does Not Pass Yet. With 3 of 8 criteria met, the primary area to monitor is: Price above 150 & 200 DMA, 200 DMA trending up, Price above 50 DMA, 30% above 52W low, RS Rating ≥70. This is a structural methodology assessment only — not a recommendation to deploy or exit capital. This is a structural methodology assessment only — not a recommendation to deploy or exit capital.